Ishii K, Gerszten R, Zheng Y W, Welsh J B, Turck C W, Coughlin S R
Cardiovascular Research Institute, University of California, San Francisco 94143, USA.
J Biol Chem. 1995 Jul 7;270(27):16435-40. doi: 10.1074/jbc.270.27.16435.
Thrombin receptor cleavage at the Arg41- decreases -Ser42 peptide bond in the receptor's amino-terminal exodomain is necessary and sufficient for receptor activation. The rate of receptor cleavage at this site is a critical determinant of the magnitude of the cellular response to thrombin. These observations underscore the importance of defining the molecular basis for thrombin-receptor interaction and cleavage. We report that chimeric proteins bearing only thrombin receptor amino-terminal exodomain residues 36-60 are cleaved at rates similar to the wild-type thrombin receptor when expressed on the cell surface. A soluble amino-terminal exodomain protein was also cleaved efficiently by thrombin with a Km of 15-30 microM and k(cat) of approximately 50 s-1, with cleavage occurring only at the Arg41- decreases -Ser42 peptide bond. In the context of previous studies, these data suggest that the receptor's LDPR cleavage recognition sequence and DKYEPF hirudin-like domain account for thrombin-receptor interaction. Because a P3 aspartate in protein C's cleavage site inhibits cleavage by free thrombin, we investigated the role of the P3 aspartate in the receptor's LDPR sequence. Studies with mutant receptors revealed an inhibitory role for this residue only in the absence of the receptor's hirudin-like domain. These and other data suggest that the receptor's hirudin-like domain causes a conformational change in thombin's active center to accommodate the LDPR sequence and promote efficient receptor cleavage. Taken together, these studies imply that the thrombin receptor's amino-terminal exodomain contains all the machinery needed for efficient recognition and cleavage by thrombin. Thrombin appears to bind and cleave this domain independently of the rest of the receptor, with one thrombin molecule probably activating multiple receptors.
凝血酶受体在其氨基末端胞外域的精氨酸41-减少-丝氨酸42肽键处的裂解对于受体激活是必要且充分的。该位点的受体裂解速率是细胞对凝血酶反应强度的关键决定因素。这些观察结果强调了确定凝血酶-受体相互作用和裂解分子基础的重要性。我们报告,仅携带凝血酶受体氨基末端胞外域残基36-60的嵌合蛋白在细胞表面表达时,其裂解速率与野生型凝血酶受体相似。一种可溶性氨基末端胞外域蛋白也能被凝血酶有效裂解,其Km为15-30微摩尔,k(cat)约为50秒-1,且裂解仅发生在精氨酸41-减少-丝氨酸42肽键处。结合之前的研究,这些数据表明受体的LDPR裂解识别序列和DKYEPF水蛭素样结构域负责凝血酶-受体相互作用。由于蛋白C裂解位点中的P3天冬氨酸抑制游离凝血酶的裂解,我们研究了P3天冬氨酸在受体LDPR序列中的作用。对突变受体的研究表明,仅在没有受体水蛭素样结构域的情况下,该残基具有抑制作用。这些以及其他数据表明,受体的水蛭素样结构域会导致凝血酶活性中心发生构象变化,以容纳LDPR序列并促进有效的受体裂解。综上所述,这些研究表明凝血酶受体的氨基末端胞外域包含凝血酶有效识别和裂解所需的所有机制。凝血酶似乎独立于受体的其余部分结合并裂解该结构域,一个凝血酶分子可能激活多个受体。